Antirheumatic agents
Showing 1 - 25 of 5,462
Hydroxychloroquine, Antimalarials, Enzyme Inhibitors Trial in Mexico City (Hydroxychloroquine Sulfate, Bromhexine 8 MG)
Enrolling by invitation
- Hydroxychloroquine
- +3 more
- Hydroxychloroquine Sulfate
- Bromhexine 8 MG
-
Mexico City, Cdmx, MexicoNational Institute of Rehabilitation, Luis Guillermo Ibarra Ibar
Jun 26, 2021
Myocardial Infarction, Acute Coronary Syndrome, Inflammation Trial in Finland (Hydroxychloroquine, Placebo)
Completed
- Myocardial Infarction
- +5 more
- Hydroxychloroquine
- Placebo
-
Helsinki, Finland
- +5 more
Jun 6, 2020
Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory DLBCL Trial in Canada (DPX-Survivac, Pembrolizumab,
Active, not recruiting
- Adult Diffuse Large Cell Lymphoma
- +2 more
- DPX-Survivac
- +2 more
-
Calgary, Alberta, Canada
- +5 more
Nov 9, 2022
Rheumatoid Arthritis Trial in Cairo (Cilostazol 100 MG, conventional synthetic antirheumatic drugs)
Recruiting
- Rheumatoid Arthritis
- Cilostazol 100 MG
- conventional synthetic antirheumatic drugs
-
Cairo, EgyptAl-Zahraa Hospital
Dec 26, 2022
Tofacitinib Special Investigation for Rheumatoid Arthritis
Completed
- Rheumatoid Arthritis
- Tofacitinib (Xeljanz)
- Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc
-
Tokyo, Japan(unnamed)
Sep 27, 2021
Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))
Not yet recruiting
- Rheumatoid Arthritis
- Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
- (no location specified)
Nov 12, 2021
Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.
Recruiting
- Rheumatoid Arthritis
- +2 more
- Infliximab: Adalimumab; Etanercept;
-
Sulaymaniyah, Kurdistan Region, IraqHiwa Khidhir Saaed
May 12, 2022
Rheumatoid Arthritis Trial in Glasgow (Active Stimulation)
Recruiting
- Rheumatoid Arthritis
- Active Stimulation
-
Glasgow, United KingdomGreater Glasgow Health Board
Oct 25, 2021
Diffuse Cutaneous Systemic Sclerosis Trial in London (Brentuximab Vedotin)
Recruiting
- Diffuse Cutaneous Systemic Sclerosis
- Brentuximab Vedotin
-
London, Ontario, CanadaRheumatology Clinic, St. Joseph's Health Care
Feb 3, 2022
Rheumatoid Arthritis Trial in Montpellier (Abatacept (M3-M12), TNF Inhibitor (M3-M12), TNF Inhibitor (M0-M3))
Not yet recruiting
- Rheumatoid Arthritis
- Abatacept (M3-M12)
- +2 more
-
Montpellier, FranceCentre Hospitalier Universitaire de Montpellier
Jun 16, 2022
Rheumatoid Arthritis Trial in United States (procedure, drug, device)
Recruiting
- Rheumatoid Arthritis
- Implant Procedure
- +3 more
-
Birmingham, Alabama
- +33 more
Jan 3, 2023
Corona Virus Infection Trial in Bogota (Colchicine 0.5 MG, CONTROL GROUP)
Terminated
- Corona Virus Infection
- Colchicine 0.5 MG
- CONTROL GROUP
-
Bogota, Cundinamarca, ColombiaFundación Universitaria de Ciencias de La Salud
Feb 7, 2022
Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")
Not yet recruiting
- Rheumatoid Arthritis
- "apigenin" and "glycyrrhizin"
- +2 more
- (no location specified)
Mar 27, 2023
Rheumatoid Arthritis Trial in Norway (TNF inhibitors, Synthetic DMARD(s), Co-medication: Synthetic DMARDs)
Active, not recruiting
- Rheumatoid Arthritis
- TNF inhibitors
- +2 more
-
Bergen, Norway
- +9 more
Sep 14, 2020
Axial Spondyloarthritis, Arthritis, Rheumatoid Trial in Portugal (biological disease-modifying antirheumatic drugs (bDMARDs))
Recruiting
- Axial Spondyloarthritis
- Arthritis, Rheumatoid
- biological disease-modifying antirheumatic drugs (bDMARDs)
-
Aveiro, Portugal
- +9 more
Jul 12, 2021
The Norwegian Antirheumatic Drug Register
Recruiting
- Inflammatory Joint Diseases
-
Drammen, Buskerud, Norway
- +5 more
Aug 19, 2022
Arthritis, Rheumatoid, Arthritis, Psoriatic, Spondyloarthritis Trial in Caba, Ciudad Autonoma Buenos Aires (DMARDs, biologic
Recruiting
- Arthritis, Rheumatoid
- +2 more
- DMARDs
- +2 more
-
Caba, Buenos Aires, Argentina
- +1 more
Mar 26, 2021
SAPHO Syndrome Trial in Warsaw (Etanercept, Placebo)
Recruiting
- SAPHO Syndrome
- Etanercept
- Placebo
-
Warsaw, Mazowieckie, PolandCentrum Wsparcia Badań Klinicznych
Aug 29, 2023
Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)
Terminated
- Rheumatoid Arthritis
- Methotrexate
- +5 more
-
Pondicherry, IndiaDepartment of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021
Predictive Factors for COVID-19 in Rheumatology
Not yet recruiting
- Rheumatic Diseases
- Covid19
- Disease-modifying antirheumatic drugs (DMARDs)
- (no location specified)
Sep 24, 2020